Underwater Endoscopic Mucosal Resection
1 other identifier
interventional
90
1 country
1
Brief Summary
The global aim of this multi-centric study is to assess the learning curve of U-EMR by an endoscopist skilled in C-EMR aiming to assess the application in real world and check the rate of complete EMR and adverse events related to the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedApril 30, 2024
April 1, 2024
6 months
October 4, 2023
April 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
learning curve of the application of U-EMR by endoscopists skilled in C-EMR
evaluate the learning curve of the application of U-EMR by endoscopists skilled in C-EMR after an online course about U-EMR technique.
6 months
Study Arms (1)
Underwater mucosectomy
EXPERIMENTALEvery colonoscopy should be performed with a high definition colonoscope, such as Olympus series Q185 or Q190 with virtual chromoendoscopy by NBI (Olympus Inc., Tokyo, Japan) or Fujifilm EC-760R-V/L or EC-760Z-V/L with virtual chromoendoscopy by LBI (Fujifilm Group, Japan). A study investigator or a senior endoscopy fellow under their direct supervision should perform all procedures. The U-EMR procedure should include the following steps: CO2 should be completely removed, and the bowel lumen filled with normal saline using a water jet pump (OFP-2, Olympus Medical System or similar) until the lesion is totally immersed in water. The lesion and 2-3 mm of normal surrounding mucosa should be resected using electrocauterization (VIO 200D Endocut Q Effect 3; ERBE Electromedizin, Tübingen, Germany).
Interventions
Patients will be submitted to underwater mucosectomy (U-EMR)
Eligibility Criteria
You may qualify if:
- Age: 18 years-old or older with at least one large (\>10 and \<30 mm) non pedunculated polyp
- Agreement with study's procedures, having signed the informed consent for the study and EMR, prior to the procedure
You may not qualify if:
- Previous attempted resection
- Lesion located at ileo-cecal valve or appendiceal orifice
- Fully circumferential lesion
- Pedunculated polyps (Paris classification type Ip) and ulcerated depression lesions (Paris classification type III)
- Surface pattern suggestive of deep invasion (ex: narrow-band imaging (NBI) International Colorectal Endoscopic (NICE) classification type 3 criteria, Kudo V or equivalent)
- Invasive cancer at EMR specimen
- Inflammatory bowel disease
- Familial polyposis syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Português de Oncologia de Lisboa Francisco Gentil
Lisbon, 1099-023, Portugal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Degree
Study Record Dates
First Submitted
October 4, 2023
First Posted
October 10, 2023
Study Start
January 1, 2024
Primary Completion
June 30, 2024
Study Completion
July 31, 2024
Last Updated
April 30, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share